Events
Allogeneic Cell Therapies Summit 2022
18 – 20 January, London
Neil Fish, Vice President of Business Development, will be attending the Allogeneic Cell Therapies Summit 2022 where experts from cell therapy and regenerative medicines will assemble to discuss strategies to tackle complex regulatory requirements in the EU, achieve large scale manufacture and improve cryopreservation to allow a more consistent, reliable product to be created, at a lower cost.
For more information, click here.
Advanced Therapy Showcase Tokyo – Webinar
28 January, Tokyo
Neil Fish, Vice President of Business Development, will be attending the Advanced Therapy Showcase Tokyo webinar. The ATST focuses on product and technology platform developers in the field of advanced therapy including, but not limited to, regenerative medicine, cell and gene therapy (CGT), nucleic acid therapy, and extracellular vesicles. The international event is a lively interaction platform for partner seekers at both ends.
For more information, click here.
Orphan Drugs & Rare Diseases Global Congress 2022 Europe
16 – 18 February, London
Neil Fish, VP of Business Development, will be attending the 16th Orphan Drugs and Rare Diseases Global Congress in February 2022. The conference provides a unique platform for the convergence of stakeholders in the orphan drug industry to discuss and network with government, pharmaceuticals, biotechs, non-profit organisations, orphan drug developers, research organisations, as well as patient groups and advocates. The 2-day congress will provide an interactive, cutting edge, and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry.
For more information, click here.
Building Life Science Adventures 2022
1 – 2 March, London
We are excited to announce Boyds as official sponsors of this years Building Life Science Adventures event by One Nucleus. Professor Alan Boyd, President and CEO of Boyds, will be chairing a session at the event on Entrepreneurship. The event brings together students, early career seekers, employers and universities across two days to discuss how to create and access great careers within the Life Science industry.
For more information, click here.
ASGCT 25th Annual Meeting
16 – 19 May, London
Neil Fish, will be attending The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting, celebrating its 25th year in 2022, an event for professionals in gene and cell therapy. The four-day meeting is a place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers. Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory agencies, equipment manufacturers, patient advocates, and more.
For more information, click here.
Advanced Therapies Live Conference 2022
23 – 25 May, London
Neil Fish, Vice President of Business Development, will be attending Advanced Therapies Congress 2022, exploring the most current topics in the ATMP space alongside a faculty of industry-leading speakers. The in-person event will showcase the latest technologies and advancements in the industry.
For more information, click here.
Bio International Convention
13 – 16 June, San Diego
Neil Fish, will be attending The Bio International Convention 2022. The BIO Convention attracts 15,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. Bio brings together a wide spectrum of life science and application, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy. This upcoming convention theme of ‘LIMITLESS’ is BIO’s commitment to unlocking possibilities for their members and attendees while paving the path to the future of the industry.
For more information, click here.